International Extranodal Lymphoma Study Group (ielsg)
Clinical trials sponsored by International Extranodal Lymphoma Study Group (ielsg), explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can PET scans better predict lymphoma outcomes? Results expected Oct 2026 (estimated)
- New hope for lymphoma patients who Can't take chemo Results expected Dec 2026 (estimated)
- Scientists dive into DNA of rare lymphoma to predict outcomes Results expected Dec 2026 (estimated)
- New hope for marginal zone lymphoma: Chemo-Free combo shows promise Results expected Jun 2027 (estimated)
- New drug cocktail aims to control Hard-to-Treat lymphoma Results expected Sep 2027 (estimated)
-
Scientists dive into DNA of rare lymphoma to predict outcomes
Knowledge-focused Recruiting nowThis study looks at tumor samples from 300 people with nodal marginal zone lymphoma, a rare blood cancer. Researchers want to find genetic patterns that help predict how the disease will behave. The goal is to better understand the disease and improve future treatment decisions.
Sponsor: International Extranodal Lymphoma Study Group (IELSG) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Scientists hunt for genetic clues in rare lymphoma that turns deadly
Knowledge-focused Recruiting nowThis study is looking at a rare and aggressive form of lymphoma called transformed splenic marginal zone lymphoma (t-SMZL). The goal is to understand the genetic changes that happen when the disease transforms and becomes harder to treat. Researchers will analyze tumor samples fr…
Sponsor: International Extranodal Lymphoma Study Group (IELSG) • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC